These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Early-onset toe walking in rippling muscle disease due to a new caveolin-3 gene mutation. Madrid RE; Kubisch C; Hays AP Neurology; 2005 Oct; 65(8):1301-3. PubMed ID: 16247063 [TBL] [Abstract][Full Text] [Related]
13. Bedside diagnosis of rippling muscle disease in CAV3 p.A46T mutation carriers. Sundblom J; Stålberg E; Osterdahl M; Rücker F; Montelius M; Kalimo H; Nennesmo I; Islander G; Smits A; Dahl N; Melberg A Muscle Nerve; 2010 Jun; 41(6):751-7. PubMed ID: 20229577 [TBL] [Abstract][Full Text] [Related]
14. Rippling muscle disease and cardiomyopathy associated with a mutation in the CAV3 gene. Catteruccia M; Sanna T; Santorelli FM; Tessa A; Di Giacopo R; Sauchelli D; Verbo A; Lo Monaco M; Servidei S Neuromuscul Disord; 2009 Nov; 19(11):779-83. PubMed ID: 19773168 [TBL] [Abstract][Full Text] [Related]
15. Caveolinopathies: translational implications of caveolin-3 in skeletal and cardiac muscle disorders. Gazzerro E; Bonetto A; Minetti C Handb Clin Neurol; 2011; 101():135-42. PubMed ID: 21496630 [TBL] [Abstract][Full Text] [Related]
16. CAV3 T78M mutation as polymorphic variant in South Italy. Spadafora P; Liguori M; Andreoli V; Quattrone A; Gambardella A Neuromuscul Disord; 2012 Jul; 22(7):669-70; author reply 670-1. PubMed ID: 22595201 [No Abstract] [Full Text] [Related]
17. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Betz RC; Schoser BG; Kasper D; Ricker K; Ramírez A; Stein V; Torbergsen T; Lee YA; Nöthen MM; Wienker TF; Malin JP; Propping P; Reis A; Mortier W; Jentsch TJ; Vorgerd M; Kubisch C Nat Genet; 2001 Jul; 28(3):218-9. PubMed ID: 11431690 [TBL] [Abstract][Full Text] [Related]